Back to top

Image: Bigstock

Compared to Estimates, Sarepta Therapeutics (SRPT) Q2 Earnings: A Look at Key Metrics

Read MoreHide Full Article

For the quarter ended June 2024, Sarepta Therapeutics (SRPT - Free Report) reported revenue of $362.93 million, up 38.9% over the same period last year. EPS came in at $0.07, compared to -$0.27 in the year-ago quarter.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Sarepta Therapeutics, Inc. (SRPT) - free report >>

Published in